http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0168235-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_247e4ca299d5654a40f71fa50f6d8dd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4eae951c9fbcf5a0bca29cfe8634087d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbef72851725dc274a2edab640d442b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37b36726b8c2d3a2fe627ab8caf1e052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc1c0db165c9a5c9c856f1047956cbf
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y30-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J13-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J13-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J13-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J13-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J13-06
filingDate 2001-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b6a877a7ebc8155fc1443547ca2632e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56171c82089eaf9252ca5a3f408b079b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32e267cbc05dc3e9023a5261415f5f74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d00dda01fc0dc983f1b533f2c30070e4
publicationDate 2001-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0168235-A1
titleOfInvention Method for preparing colloidal particles in the form of nanocapsules
abstract The invention concerns a method for preparing dispersible colloidal systems, in the form of nanocapsules whereof the shell wall consists of a polymer obtained by polycondensation of two monomers alpha and beta and whereof the core consists of a substance B, characterised in that it consists in: (1) preparing a first liquid phase consisting of a monomer alpha solution in a solvent or a mixture of solvents, and containing one or several surfactant(s) and the substance B in solution or in suspension; (2) preparing a second liquid phase consisting of a non-solvent or a mixture of non-solvents of monomer alpha , containing monomer beta and one or several surfactant(s), the solvent or mixture of solvents of the first phase being miscible in all proportions with the non-solvent or mixture of non-solvents of the second phase; (3) adding under moderate stirring, the first phase to the second phase, so as to obtain a colloidal suspension of nanocapsules, the stirring being maintained until complete polymerisation of monomers alpha and beta ; (4) optionally eliminating all or part of the solvent or mixture of solvents and of the non-solvent or mixture of non-solvents so as to obtain a colloidal suspension with the desired concentration in nanocapsules.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9724302-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1306127-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03035244-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006514698-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9730892-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7740938-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9737482-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9737483-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10045941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006067307-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10398648-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7468151-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2879476-A1
priorityDate 2000-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06170214-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5500224-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9415590-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9413139-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07116500-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128005914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226498496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11443
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69329926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397879
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23286221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994

Total number of triples: 62.